Cost benefit analysis for reduction of air pollution
At the Institute of Pharmaceutical Sciences (TIPS)’s Scientific Meeting held online on November 28, 2021, the topic of "Cost benefit analysis for reduction of air pollution" was presented by Dr. Sh. Mozafari. In this meeting, the health impacts of particulate air pollution, as well as the economic benefits following decreasing levels of air particulates, were discussed.
It is concluded that the potential health and economic benefits of reducing particulate matter concentration in the air can be significant by mortality rate which will result in large monetary benefits.
Send to friends